EdgarLookup

INNODATA INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that INNODATA INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
37.1%
Profit Margin
Net income ÷ revenue
19.1%
Return on Assets
Net income ÷ assets
0.57x
Debt-to-Equity
Total liabilities ÷ equity
+9.8%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $86.78M Mar 4, 2024
FY2023 Dec 31, 2022 $79.00M Mar 4, 2024
FY2022 Dec 31, 2021 $69.76M Feb 24, 2023
FY2021 Dec 31, 2020 $58.24M Mar 24, 2022
FY2020 Dec 31, 2019 $55.86M Mar 15, 2021
FY2019 Dec 31, 2018 $57.42M Mar 16, 2020
FY2018 Dec 31, 2017 $60.93M Mar 26, 2019
FY2016 Dec 31, 2016 $15.67M Mar 15, 2017
FY2016 Sep 30, 2016 $16.06M Mar 15, 2017
FY2016 Jun 30, 2016 $15.64M Mar 15, 2017

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $251.66M Feb 26, 2026
FY2025 Dec 31, 2024 $170.46M Feb 26, 2026
FY2024 Dec 31, 2023 $86.78M Feb 24, 2025

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $99.48M Feb 26, 2026
FY2025 Dec 31, 2024 $67.07M Feb 26, 2026
FY2024 Dec 31, 2023 $31.29M Feb 24, 2025
FY2016 Dec 31, 2016 $4.03M Mar 15, 2017
FY2016 Sep 30, 2016 $3.64M Mar 15, 2017
FY2016 Jun 30, 2016 $3.96M Mar 15, 2017
FY2016 Mar 31, 2016 $4.23M Mar 15, 2017
FY2016 Dec 31, 2015 $4.15M Mar 15, 2017
FY2016 Sep 30, 2015 $4.68M Mar 15, 2017
FY2016 Jun 30, 2015 $3.07M Mar 15, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $32.18M Feb 26, 2026
FY2025 Dec 31, 2024 $28.66M Feb 26, 2026
FY2024 Dec 31, 2023 ($908.0K) Feb 24, 2025
FY2023 Dec 31, 2022 ($11.94M) Mar 4, 2024
FY2022 Dec 31, 2021 ($1.67M) Feb 24, 2023
FY2021 Dec 31, 2020 $617.0K Mar 24, 2022
FY2021 Dec 31, 2019 $617.0K Mar 24, 2022
FY2019 Dec 31, 2018 ($253.0K) Mar 16, 2020
FY2018 Dec 31, 2017 ($5.06M) Mar 26, 2019
FY2016 Dec 31, 2016 ($983.0K) Mar 15, 2017

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $39.87M Feb 26, 2026
FY2025 Dec 31, 2024 $24.34M Feb 26, 2026
FY2024 Dec 31, 2023 $318.0K Feb 24, 2025
FY2017 Dec 31, 2017 ($5.10M) Mar 22, 2018
FY2017 Dec 31, 2016 ($4.72M) Mar 22, 2018
FY2016 Dec 31, 2015 ($2.21M) Mar 15, 2017
FY2016 Dec 31, 2014 ($1.62M) Mar 15, 2017
FY2015 Dec 31, 2013 ($7.70M) Mar 14, 2016
FY2014 Dec 31, 2012 $6.52M Mar 13, 2015
FY2013 Dec 31, 2011 $4.68M Mar 14, 2014

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $59.61M Feb 26, 2026
FY2025 Dec 31, 2024 $42.74M Feb 26, 2026
FY2024 Dec 31, 2023 $30.98M Feb 24, 2025
FY2023 Dec 31, 2022 $37.94M Mar 4, 2024
FY2022 Dec 31, 2021 $27.91M Feb 24, 2023
FY2021 Dec 31, 2020 $18.66M Mar 24, 2022
FY2020 Dec 31, 2019 $19.48M Mar 15, 2021
FY2019 Dec 31, 2018 $15.85M Mar 16, 2020
FY2018 Dec 31, 2017 $20.20M Mar 26, 2019
FY2017 Dec 31, 2016 $19.54M Mar 22, 2018

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $46.75M Feb 26, 2026
FY2025 Dec 31, 2024 $34.86M Feb 26, 2026
FY2024 Dec 31, 2023 $5.90M Feb 24, 2025
FY2023 Dec 31, 2022 ($1.22M) Mar 4, 2024
FY2022 Dec 31, 2021 $5.15M Feb 24, 2023
FY2021 Dec 31, 2020 $5.66M Mar 24, 2022
FY2020 Dec 31, 2019 $4.28M Mar 15, 2021
FY2019 Dec 31, 2018 $3.57M Mar 16, 2020
FY2018 Dec 31, 2017 $639.0K Mar 26, 2019
FY2017 Dec 31, 2016 ($2.74M) Mar 22, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.10M Feb 26, 2026
FY2025 Dec 31, 2024 $7.74M Feb 26, 2026
FY2024 Dec 31, 2023 $5.56M Feb 24, 2025
FY2023 Dec 31, 2022 $6.53M Mar 4, 2024
FY2022 Dec 31, 2021 $4.37M Feb 24, 2023
FY2021 Dec 31, 2020 $1.41M Mar 24, 2022
FY2020 Dec 31, 2019 $1.67M Mar 15, 2021
FY2019 Dec 31, 2018 $2.03M Mar 16, 2020
FY2018 Dec 31, 2017 $3.41M Mar 26, 2019
FY2017 Dec 31, 2016 $2.74M Mar 22, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $168.59M Feb 26, 2026
FY2025 Dec 31, 2024 $113.45M Feb 26, 2026
FY2024 Dec 31, 2023 $59.43M Feb 24, 2025
FY2023 Dec 31, 2022 $48.04M Mar 4, 2024
FY2022 Dec 31, 2021 $59.22M Feb 24, 2023
FY2021 Dec 31, 2020 $57.25M Mar 24, 2022
FY2020 Dec 31, 2019 $49.50M Mar 15, 2021
FY2019 Dec 31, 2018 $44.94M Mar 16, 2020
FY2018 Dec 31, 2017 $47.87M Mar 26, 2019
FY2017 Dec 31, 2016 $47.59M Mar 22, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $61.53M Feb 26, 2026
FY2025 Dec 31, 2024 $50.06M Feb 26, 2026
FY2024 Dec 31, 2023 $34.44M Feb 24, 2025
FY2023 Dec 31, 2022 $30.00M Mar 4, 2024
FY2022 Dec 31, 2021 $32.81M Feb 24, 2023
FY2021 Dec 31, 2020 $31.00M Mar 24, 2022
FY2020 Dec 31, 2019 $27.38M Mar 15, 2021

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $107.15M Feb 26, 2026
FY2025 Dec 31, 2024 $63.47M Feb 26, 2026
FY2024 Dec 31, 2023 $25.70M Feb 24, 2025
FY2024 Dec 31, 2022 $18.77M Feb 24, 2025
FY2023 Dec 31, 2021 $29.93M Mar 4, 2024
FY2022 Dec 31, 2020 $29.64M Feb 24, 2023
FY2020 Dec 31, 2019 $25.53M Mar 15, 2021
FY2020 Dec 31, 2018 $29.58M Mar 15, 2021
FY2019 Dec 31, 2017 $30.62M Mar 16, 2020
FY2018 Dec 31, 2016 $33.78M Mar 26, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.08M Feb 26, 2026
FY2025 Dec 31, 2024 $2.00M Feb 26, 2026
FY2024 Dec 31, 2023 $2.08M Feb 24, 2025
FY2023 Dec 31, 2022 $2.04M Mar 4, 2024
FY2022 Dec 31, 2021 $2.14M Feb 24, 2023
FY2021 Dec 31, 2020 $2.15M Mar 24, 2022
FY2020 Dec 31, 2019 $2.11M Mar 15, 2021
FY2020 Dec 31, 2018 $2.05M Mar 15, 2021
FY2019 Dec 31, 2017 $2.83M Mar 16, 2020
FY2018 Dec 31, 2016 $2.73M Mar 26, 2019

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $51.16M Feb 26, 2026
FY2025 Dec 31, 2024 $18.98M Feb 26, 2026
FY2024 Dec 31, 2023 ($9.68M) Feb 24, 2025
FY2023 Dec 31, 2022 ($8.78M) Mar 4, 2024
FY2022 Dec 31, 2021 $3.16M Feb 24, 2023
FY2021 Dec 31, 2020 $4.83M Mar 24, 2022
FY2020 Dec 31, 2019 $4.22M Mar 15, 2021
FY2019 Dec 31, 2018 $6.60M Mar 16, 2020
FY2018 Dec 31, 2017 $7.35M Mar 26, 2019
FY2017 Dec 31, 2016 $12.40M Mar 22, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $82.23M Feb 26, 2026
FY2025 Dec 31, 2024 $46.90M Feb 26, 2026
FY2024 Dec 31, 2023 $13.81M Feb 24, 2025
FY2023 Dec 31, 2022 $9.79M Mar 4, 2024
FY2022 Dec 31, 2021 $18.90M Feb 24, 2023
FY2021 Dec 31, 2020 $17.57M Mar 24, 2022
FY2020 Dec 31, 2019 $10.87M Mar 15, 2021
FY2019 Dec 31, 2018 $10.87M Mar 16, 2020
FY2018 Dec 31, 2017 $11.41M Mar 26, 2019
FY2018 Dec 31, 2016 $14.17M Mar 26, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $5.96M Feb 24, 2023
FY2022 Dec 31, 2021 $7.50M Feb 24, 2023
FY2021 Dec 31, 2020 $7.99M Mar 24, 2022
FY2020 Dec 31, 2019 $5.97M Mar 15, 2021
FY2019 Dec 31, 2018 $5.59M Mar 16, 2020
FY2018 Dec 31, 2017 $7.81M Mar 26, 2019
FY2017 Dec 31, 2016 $5.04M Mar 22, 2018
FY2016 Dec 31, 2015 $5.02M Mar 15, 2017
FY2015 Dec 31, 2014 $7.15M Mar 14, 2016
FY2014 Dec 31, 2013 $4.10M Mar 13, 2015

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 26, 2026
FY2025 Dec 31, 2024 0 Feb 26, 2026
FY2024 Dec 31, 2023 0 Feb 24, 2025
FY2023 Dec 31, 2022 0 Mar 4, 2024
FY2022 Dec 31, 2021 0 Feb 24, 2023
FY2021 Dec 31, 2020 0 Mar 24, 2022
FY2020 Dec 31, 2019 0 Mar 15, 2021
FY2014 Dec 31, 2014 0 Mar 13, 2015
FY2013 Dec 31, 2013 0 Mar 14, 2014
FY2013 Sep 30, 2013 0 Mar 14, 2014

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 0 Feb 26, 2026
FY2025 Dec 31, 2024 0 Feb 26, 2026
FY2024 Dec 31, 2023 0 Feb 24, 2025
FY2023 Dec 31, 2022 0 Mar 4, 2024
FY2022 Dec 31, 2021 0 Feb 24, 2023
FY2021 Dec 31, 2020 0 Mar 24, 2022
FY2020 Dec 31, 2019 0 Mar 15, 2021
FY2015 Dec 31, 2014 0 Mar 14, 2016
FY2013 Dec 31, 2013 0 Mar 14, 2014
FY2013 Sep 30, 2013 0 Mar 14, 2014

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 32.34M Feb 26, 2026
FY2025 Dec 31, 2024 31.30M Feb 26, 2026
FY2024 Dec 31, 2023 28.75M Feb 24, 2025
FY2023 Dec 31, 2022 27.41M Mar 4, 2024
FY2022 Dec 31, 2021 27.16M Feb 24, 2023
FY2021 Dec 31, 2020 25.80M Mar 24, 2022
FY2020 Dec 31, 2019 24.46M Mar 15, 2021
FY2019 Dec 31, 2018 25.88M Mar 16, 2020
FY2018 Dec 31, 2017 25.88M Mar 26, 2019
FY2017 Dec 31, 2016 25.62M Mar 22, 2018